JPRN-UMIN000023331已完成未知
Efficacy of Eribulin Monotherapy in Patients with Unresectable Angiosarcoma--A Multicenter Prospective Observational Study - Erbulin monotherapy for angiosarcoma
niversity of Tsukuba0 个研究点目标入组 30 人开始时间: 2016年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
Primary endpoint:OS
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe bone marrow suppression 2) Presence of uncontrolled hemopneumothorax 3) Pregnancy or possibility of pregnancy 4) Investigator's decision
研究者
相似试验
已完成
2 期
Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who presented well-defined taxane resistanceBreast CancerJPRN-UMIN000006965Saitama Breast Cancer Clinical Study Group (SBCCSG)52
进行中（未招募）
不适用
A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).Breast CancerNCT05953909Fujian Cancer Hospital120
已完成
2 期
A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancercolorectal cancerJPRN-UMIN000031221Aichi Cancer Center Hospital30
招募中
2 期
A phase II study of eribulin monotherapy for advanced extramammary Paget's diseaseJPRN-jRCT2011220022Yanagi Teruki18
已完成
不适用
A poilot study of eribulin monotherapy in chemorefractory patients with BRAF V600E-mutant metastatic colorectal cancercolorectal cancerJPRN-UMIN000027648Aichi Cancer Center Hospital5